Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.7400
-0.0200 (-2.63%)
Apr 22, 2026, 3:30 PM EST
Vaxart Employees
Vaxart had 65 employees as of December 31, 2025. The number of employees decreased by 40 or -38.10% compared to the previous year.
Employees
65
Change (1Y)
-40
Growth (1Y)
-38.10%
Revenue / Employee
$3,650,123
Profits / Employee
$251,185
Market Cap
178.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 65 | -40 | -38.10% |
| Dec 31, 2024 | 105 | -4 | -3.67% |
| Dec 31, 2023 | 109 | -55 | -33.54% |
| Dec 31, 2022 | 164 | 54 | 49.09% |
| Dec 31, 2021 | 110 | 82 | 292.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsVaxart News
- 6 days ago - Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital - GlobeNewsWire
- 7 weeks ago - Vaxart to Host Upcoming Conference Calls - GlobeNewsWire
- 3 months ago - Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - GlobeNewsWire
- 6 months ago - Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program - PRNewsWire
- 6 months ago - Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program - PRNewsWire
- 7 months ago - Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025 - GlobeNewsWire
- 7 months ago - Vaxart Appoints W. Mark Watson as Lead Independent Director - GlobeNewsWire
- 8 months ago - Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate - GlobeNewsWire